ClinicalTrials.Veeva

Menu

The Effects of Butyrate Enemas on Visceral Perception

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Visceral (Hyper)Sensitivity

Treatments

Drug: Butyrate

Study type

Interventional

Funder types

Other

Identifiers

NCT00726817
MEC 06-3-020

Details and patient eligibility

About

During this double blind, placebo controlled, randomised cross over study, healthy volunteers received an enema once daily for one week containing either placebo (saline), 50mM butyrate or 100mM of butyrate. Before and directly after each test period a barostat protocol was performed to measure parameters for visceral perception.

Enrollment

11 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy

Exclusion criteria

  • age, under 18 or over 65
  • use of pre- or probiotics during study and 3 months previous to study
  • previous bowel complaints
  • gastrointestinal disease or abdominal surgery

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

11 participants in 3 patient groups, including a placebo group

1
Placebo Comparator group
Description:
enemas, once daily, containing saline
Treatment:
Drug: Butyrate
2
Experimental group
Description:
enemas, once daily, containing 50mM butyrate
Treatment:
Drug: Butyrate
3
Experimental group
Description:
enemas, once daily, containing 100mM butyrate
Treatment:
Drug: Butyrate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems